Demographic and Clinical Factors Associated With SARS-CoV-2 Spike 1 Antibody Response Among Vaccinated US Adults: the C4R Study

JS Kim, Y Sun, P Balte, M Cushman, R Boyle… - Nature …, 2024 - nature.com
This study investigates correlates of anti-S1 antibody response following COVID-19
vaccination in a US population-based meta-cohort of adults participating in longstanding …

The subdued post-boost spike-directed secondary igG antibody response in Ugandan recipients of the pfizer-bioNTech BNT162b2 vaccine has implications for local …

V Ankunda, JS Katende, GK Oluka, J Sembera… - Frontiers in …, 2024 - frontiersin.org
Introduction This study aimed to delineate longitudinal antibody responses to the Pfizer-
BioNTech BNT162b2 COVID-19 vaccine within the Ugandan subset of the Sub-Saharan …

Immune response stability to the SARS-CoV-2 mRNA vaccine booster is influenced by differential splicing of HLA genes

CB Santos-Rebouças, CS Ferreira, JS Nogueira… - Scientific Reports, 2024 - nature.com
Many molecular mechanisms that lead to the host antibody response to COVID-19 vaccines
remain largely unknown. In this study, we used serum antibody detection combined with …

Antibody neutralization capacity after coronavirus disease 2019 vaccination in people with HIV in Canada

CT Costiniuk, J Singer, T Lee, Y Galipeau… - AIDS, 2023 - journals.lww.com
Objectives: Many vaccines require higher/additional doses or adjuvants to provide adequate
protection for people with HIV (PWH). Here, we compare coronavirus disease 2019 (COVID …

Immunogenicity of concomitant SARS-CoV-2 and influenza vaccination in UK healthcare workers: a prospective longitudinal observational study

J Nazareth, CA Martin, D Pan, IG Barr… - The Lancet Regional …, 2024 - thelancet.com
Background Co-administration of inactivated influenza vaccine (IIV) and SARS-CoV-2
vaccine may impact SARS-CoV-2 vaccine induced humoral immune responses. We aimed …

[HTML][HTML] Anti-SARS-CoV-2 spike antibody response to the third dose of BNT162b2 mRNA COVID-19 vaccine and associated factors in Japanese hemodialysis …

K Hirai, M Shimotashiro, T Okumura… - Kidney Research and …, 2024 - ncbi.nlm.nih.gov
Background We assessed the anti-SARS-CoV-2 spike antibody response to the third dose of
BNT162b2 mRNA COVID-19 vaccine in Japanese hemodialysis patients and determined …

[HTML][HTML] Immunogenicity and Predictive Factors Associated with Poor Response after Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in Lung …

SJ Lee, A Woo, JA Lee, Y Lee, HE Kim, JG Lee, SY Kim… - Vaccines, 2024 - ncbi.nlm.nih.gov
Lung transplant patients are more likely to develop severe coronavirus disease 2019
(COVID-19) compared with the general population and should be vaccinated against severe …

[HTML][HTML] Dynamics of T-cell responses following COVID-19 mRNA vaccination and breakthrough infection in older adults

S Datwani, R Kalikawe, F Mwimanzi… - Pathogens and …, 2023 - ncbi.nlm.nih.gov
Methods: We quantified CD4+ and CD8+ T-cells reactive to overlapping peptides spanning
the ancestral SARS-CoV-2 spike protein in 40 older adults (median age 79) and 50 younger …

Antibody neutralization capacity after COVID-19 vaccination in people with HIV (CIHR Canadian HIV trials network 328)

CT Costiniuk, J Singer, T Lee, Y Galipeau… - AIDS, 2023 - journals.lww.com
Objectives: Many vaccines require higher/additional doses or adjuvants to provide adequate
protection for people living with HIV (PLWH). Here, we compare COVID-19 vaccine-induced …

Investigating incidence of and factors associated with SARS-CoV-2 infection over a nine-month period in a highly-vaccinated healthcare worker cohort

L Townsend, L Marron, K O'Brien… - … Journal of Medicine, 2024 - academic.oup.com
Abstract Background Healthcare workers (HCWs) are at increased risk of SARS-CoV-2
infection. This risk persists despite the implementation of mitigating factors, including …